BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25398831)

  • 1. The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model.
    Scott KA; Dalgleish AG; Liu WM
    Mol Cancer Ther; 2014 Dec; 13(12):2955-67. PubMed ID: 25398831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells.
    Scott KA; Dennis JL; Dalgleish AG; Liu WM
    Anticancer Res; 2015 Nov; 35(11):5827-37. PubMed ID: 26504004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
    López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
    Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
    Marcu JP; Christian RT; Lau D; Zielinski AJ; Horowitz MP; Lee J; Pakdel A; Allison J; Limbad C; Moore DH; Yount GL; Desprez PY; McAllister SD
    Mol Cancer Ther; 2010 Jan; 9(1):180-9. PubMed ID: 20053780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
    De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V
    Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
    López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
    Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83.
    Cerretani D; Collodel G; Brizzi A; Fiaschi AI; Menchiari A; Moretti E; Moltoni L; Micheli L
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
    Torres S; Lorente M; Rodríguez-Fornés F; Hernández-Tiedra S; Salazar M; García-Taboada E; Barcia J; Guzmán M; Velasco G
    Mol Cancer Ther; 2011 Jan; 10(1):90-103. PubMed ID: 21220494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
    Brady KT; Balster RL
    Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
    Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
    Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.
    Massi P; Vaccani A; Ceruti S; Colombo A; Abbracchio MP; Parolaro D
    J Pharmacol Exp Ther; 2004 Mar; 308(3):838-45. PubMed ID: 14617682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
    Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
    Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
    Nahler G
    Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.
    Hernán Pérez de la Ossa D; Lorente M; Gil-Alegre ME; Torres S; García-Taboada E; Aberturas Mdel R; Molpeceres J; Velasco G; Torres-Suárez AI
    PLoS One; 2013; 8(1):e54795. PubMed ID: 23349970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
    Linher-Melville K; Zhu YF; Sidhu J; Parzei N; Shahid A; Seesankar G; Ma D; Wang Z; Zacal N; Sharma M; Parihar V; Zacharias R; Singh G
    PLoS One; 2020; 15(6):e0234176. PubMed ID: 32497151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of delta-9-tetrahydrocannabinol and cannabidiol on p50 of the oxygen haemoglobin dissociation curve.
    James TR; Watson CT; Pepple DJ
    Fitoterapia; 2020 Jun; 143():104539. PubMed ID: 32147492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.